From diversity to function: microbiome-mediated plant growth promotion, secondary metabolism, and antimicrobial resistance in Rauwolfia serpentina
Frontiers in Bioinformatics · 14.07.2026 · 6
DOI: 10.3389/fbinf.2026.1796770 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioinformatics, online erschienen am 14.07.2026. Verfasst von Vrishali Rajendra Bankar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Technology, Dr. Vishwanath Karad, MIT World Peace University, Pune, Maharashtra, India. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
This study presents the first metagenomic analysis of the root and rhizosphere microbiomes of Rauvolfia serpentina, an endangered medicinal plant. Metagenomic sequencing and bioinformatics analysis were used to characterize the diverse microbial communities and their functional attributes to assess the ecological and biotechnological potential of this plant-associated microbiome.
Methods
High-throughput Illumina sequencing and bioinformatics analysis were used to profile the microbial communities. Functional annotation was performed to identify plant growth-promoting traits using PLABASE, to predict pathways for the biosynthesis of novel bioactive compounds using antiSMASH, and to identify antimicrobial resistance genes using ResFinder.
Results
The analysis revealed highly diverse microbial communities in both habitats, predominantly composed of Pseudomonadota, Bacillota, and Actinomycetota, with minor but consistent contributions from archaea and eukaryotes. Functional annotation identified extensive PGPTs, including genes associated with phosphate solubilization, nitrogen fixation, siderophore-mediated iron acquisition, and stress tolerance. The rhizosphere microbiome exhibited greater metabolic versatility and stress tolerance, characterized by a higher copy number of heavy metal efflux pumps, whereas the root microbiome was enriched in genes involved in plant hormone regulation and plant-microbe interactions. A diverse array of non-ribosomal peptide synthase, polyketide synthase, and lasso peptide pathways were predicted, underscoring the potential to produce novel bioactive compounds. These distinct functional profiles demonstrates that the protected root endomicrobiome specializes in plant signalling and nutrient assimilation, while the rhizosphere microbiome, facing higher competition, specializes in nutrient acquisition and stress resilience.
Conclusion
These findings provide novel insights into the ecological specialization and biotechnological potential of the R. serpentina microbiome, offering significant implications for the sustainable utilization and conservation of this endangered medicinal plant.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biosciences and Technology, Dr. Vishwanath Karad, MIT World Peace University, Pune, Maharashtra, India.
- ICAR-Directorate of Floriculture Research, Pune, Maharashtra, India.
Zitieren
APA
Bankar, V. R., Chapadgaonkar, S. S., Bhattacharyya, K., & K, P. (2026). From diversity to function: microbiome-mediated plant growth promotion, secondary metabolism, and antimicrobial resistance in Rauwolfia serpentina. Frontiers in Bioinformatics, 6. https://doi.org/10.3389/fbinf.2026.1796770
Vancouver
Bankar VR, Chapadgaonkar SS, Bhattacharyya K, K P. From diversity to function: microbiome-mediated plant growth promotion, secondary metabolism, and antimicrobial resistance in Rauwolfia serpentina. Frontiers in Bioinformatics. 2026;6. doi:10.3389/fbinf.2026.1796770
BibTeX
@article{Bankar2026,
author = {Bankar, Vrishali Rajendra and Chapadgaonkar, Shilpa Samir and Bhattacharyya, Kausik and K, Prabha},
title = {From diversity to function: microbiome-mediated plant growth promotion, secondary metabolism, and antimicrobial resistance in Rauwolfia serpentina},
journal = {Frontiers in Bioinformatics},
year = {2026},
volume = {6},
doi = {10.3389/fbinf.2026.1796770}
}
EUVIMED